ReviewJournal of nanobiotechnology2022

Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis.

Haikun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.